EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism

Xiao Ma, Qichao Hu, Tao Jiang, Yuan Chen, Wenwen Zhang, Pan Gao, Jinhao Zeng, Thomas Efferth iD

Molecules · 26.08.2024 · 29 (17) · 4031

DOI: 10.3390/molecules29174031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 26.08.2024. Verfasst von Xiao Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 6111…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Signal Transduction, Alkaloids. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young Elite Scientists Sponsorship Program by CACM, Natural Science Foundation of Sichuan Province, China Association for Pharmaceutical Education 2022 Major Scientific Problems and Pharmaceutical Technological Difficulties Research Topics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a typical inflammatory bowel disease (IBD), impairing the quality of life of patients. Dehydroevodiamine (DHE) is an active alkaloid isolated from Tetradium ruticarpum that exerts significant anti-inflammatory effects in gastrointestinal diseases. However, the effect and mechanisms of DHE on UC remain unclear. We performed a DSS-induced experimental UC rat model to reveal the efficacy and potential mechanisms of DHE on UC. HE and AB-PAS staining were used for the evaluation of pathologies, and 16S rRNA sequencing was used to detect changes in gut microbes. Metabolomics was used to detect changes in serum metabolites. Network pharmacology and transcriptomics were conducted to reveal the underlying mechanisms of DHE for UC. HuProt proteome microarrays, molecular docking, and SPR were used to reveal the targets of action of DHE. WB, RT-qPCR, and IHC were used to assess the action effects of DHE. DHE demonstrated significant alleviation of DSS-induced colitis symptoms in rats by suppressing inflammatory and oxidative stress responses, amending colonic barrier injury, and inhibiting apoptosis. In terms of gut microbial modulation, DHE decreased the abundance of Allobaculum, Clostridium, Escherichia, Enterococcus, and Barnesiella and increased the abundance of Lactobacillus, Bifidobacterium, and SMB5. Moreover, metabolomics suggested that the regulation of DHE in DSS-induced UC rats mainly involved aminoacyl-tRNA biosynthesis, vitamin B6 metabolism, phenylalanine, tyrosine, and so on. Mechanically, DHE alleviated UC in rats by targeting AKT1, thereby inhibiting the PI3K/AKT/NF-κB signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeGastrointestinal MicrobiomeSignal TransductionAlkaloidsAnimalsMaleRatsDextran SulfateDisease Models, AnimalMolecular Docking SimulationNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRats, Sprague-Dawley

Stichwörter der Autor:innen

AKT1 inhibitormetabolomicsphytotherapysignal transductionsmall molecular inhibitortranscriptomicsulcerative colitis

Substanzen

Dextran SulfateNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktdehydroevodiamineAlkaloids

Autor:innen und Institutionen

  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
  • Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
  • Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, 55128 Mainz, Germany.

ORCID-Profile: Thomas Efferth

Förderung

  • Young Elite Scientists Sponsorship Program by CACM
  • Natural Science Foundation of Sichuan Province
  • China Association for Pharmaceutical Education 2022 Major Scientific Problems and Pharmaceutical Technological Difficulties Research Topics
  • Program of Science and Technology Department of Sichuan Province
  • Hospital of the Chengdu University of Traditional Chinese Medicine

Zitieren

APA

Ma, X., Hu, Q., Jiang, T., Chen, Y., Zhang, W., Gao, P., Zeng, J., & Efferth, T. (2024). Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism. Molecules, 29(17), 4031. https://doi.org/10.3390/molecules29174031

Vancouver

Ma X, Hu Q, Jiang T, Chen Y, Zhang W, Gao P, et al. Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism. Molecules. 2024;29(17):4031. doi:10.3390/molecules29174031

BibTeX
@article{Ma2024,
  author = {Ma, Xiao and Hu, Qichao and Jiang, Tao and Chen, Yuan and Zhang, Wenwen and Gao, Pan and Zeng, Jinhao and Efferth, Thomas},
  title = {Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {17},
  pages = {4031},
  doi = {10.3390/molecules29174031}
}
Kostenlos starten →